Antitrust Concerns and the FDA Approval Process
Date:
Location:
2141 Rayburn House Office Building, Washington, DC 20515
Witnesses
Alden Abbott Esq.
Deputy Director and Senior Legal Fellow, The Heritage Foundaiton
Scott Gottlieb M.D.
Commissioner, Food & Drug Administration
Aaron S. Kesselheim M.D., M.P.H.
Associate Professor of Medicine, Harvard Medical School
- HHRG-115-JU05-Wstate-KesselheimA-20170727.pdf
- HHRG-115-JU05-TTF-KesselheimA-20170727.pdf
- HHRG-115-JU05-Bio-KesselheimA-20170727.pdf
Erika Lietzan Esq.
Associate Professor of Law, University of Missouri School of Law
Markus H. Meier
Acting Director, Bureau of Competition, Federal Trade Commission, Assistant Director, Health Care Division
David S. Olson Esq.
Associate Professor of Law, Boston College of Law
Documents
- Notice of Hearing
- HHRG-115-JU05-WList-20170727.pdf
- Marino for the record submissions
- Cicilline for the record submission
- Gottlieb responses to questions for the record
- Chairman Goodlatte for the record submission
- HHRG-115-JU05-Transcript-20170727.pdf
Issues:
Antitrust